vs
FIRST CAPITAL INC（FCAP）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
FIRST CAPITAL INC的季度营收约是Protalix BioTherapeutics, Inc.的1.5倍（$13.5M vs $9.1M），FIRST CAPITAL INC净利率更高（36.2% vs -60.3%，领先96.5%），FIRST CAPITAL INC同比增速更快（19.0% vs -49.9%），FIRST CAPITAL INC自由现金流更多（$19.9M vs $1.6M），过去两年FIRST CAPITAL INC的营收复合增速更高（13.4% vs -6.7%）
First Capital曾用名Future Capital Holdings，是印度一家非银行金融机构，主营债务融资业务。2018年12月，该机构与IDFC银行合并，组建IDFC第一银行，合并前其股票在印度国家证券交易所和孟买证券交易所挂牌上市。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
FCAP vs PLX — 直观对比
营收规模更大
FCAP
是对方的1.5倍
$9.1M
营收增速更快
FCAP
高出68.9%
-49.9%
净利率更高
FCAP
高出96.5%
-60.3%
自由现金流更多
FCAP
多$18.3M
$1.6M
两年增速更快
FCAP
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $9.1M |
| 净利润 | $4.9M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | — | -51.1% |
| 净利率 | 36.2% | -60.3% |
| 营收同比 | 19.0% | -49.9% |
| 净利润同比 | 49.6% | -184.8% |
| 每股收益（稀释后） | $1.45 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCAPPLX
| Q4 25 | $13.5M | $9.1M | ||
| Q3 25 | $13.3M | $17.9M | ||
| Q2 25 | $12.4M | $15.7M | ||
| Q1 25 | $11.4M | $10.1M | ||
| Q4 24 | $11.3M | $18.2M | ||
| Q3 24 | $10.9M | $18.0M | ||
| Q2 24 | $10.7M | $13.5M | ||
| Q1 24 | $10.5M | — |
净利润FCAPPLX
| Q4 25 | $4.9M | $-5.5M | ||
| Q3 25 | $4.5M | $2.4M | ||
| Q2 25 | $3.8M | $164.0K | ||
| Q1 25 | $3.2M | $-3.6M | ||
| Q4 24 | $3.3M | $6.5M | ||
| Q3 24 | $2.9M | $3.2M | ||
| Q2 24 | $2.8M | $-2.2M | ||
| Q1 24 | $3.0M | — |
毛利率FCAPPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率FCAPPLX
| Q4 25 | — | -51.1% | ||
| Q3 25 | 41.8% | 11.9% | ||
| Q2 25 | 37.2% | 7.5% | ||
| Q1 25 | 34.2% | -41.0% | ||
| Q4 24 | 34.8% | 39.6% | ||
| Q3 24 | 31.5% | 22.2% | ||
| Q2 24 | 31.1% | -18.0% | ||
| Q1 24 | 33.0% | — |
净利率FCAPPLX
| Q4 25 | 36.2% | -60.3% | ||
| Q3 25 | 33.8% | 13.2% | ||
| Q2 25 | 30.4% | 1.0% | ||
| Q1 25 | 28.3% | -35.8% | ||
| Q4 24 | 28.8% | 35.6% | ||
| Q3 24 | 26.5% | 18.0% | ||
| Q2 24 | 26.5% | -16.4% | ||
| Q1 24 | 28.1% | — |
每股收益（稀释后）FCAPPLX
| Q4 25 | $1.45 | $-0.06 | ||
| Q3 25 | $1.34 | $0.03 | ||
| Q2 25 | $1.13 | $0.00 | ||
| Q1 25 | $0.97 | $-0.05 | ||
| Q4 24 | $0.97 | $0.10 | ||
| Q3 24 | $0.87 | $0.03 | ||
| Q2 24 | $0.85 | $-0.03 | ||
| Q1 24 | $0.88 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $137.8M | $48.2M |
| 总资产 | $1.3B | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FCAPPLX
| Q4 25 | — | $14.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | — | — |
股东权益FCAPPLX
| Q4 25 | $137.8M | $48.2M | ||
| Q3 25 | $132.4M | $52.9M | ||
| Q2 25 | $123.2M | $49.9M | ||
| Q1 25 | $120.1M | $45.2M | ||
| Q4 24 | $114.6M | $43.2M | ||
| Q3 24 | $116.8M | $32.4M | ||
| Q2 24 | $107.8M | $28.6M | ||
| Q1 24 | $105.7M | — |
总资产FCAPPLX
| Q4 25 | $1.3B | $82.3M | ||
| Q3 25 | $1.2B | $82.3M | ||
| Q2 25 | $1.2B | $78.5M | ||
| Q1 25 | $1.2B | $73.9M | ||
| Q4 24 | $1.2B | $73.4M | ||
| Q3 24 | $1.2B | $61.6M | ||
| Q2 24 | $1.2B | $91.5M | ||
| Q1 24 | $1.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.3M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $19.9M | $1.6M |
| 自由现金流率自由现金流/营收 | 147.7% | 17.8% |
| 资本支出强度资本支出/营收 | 10.0% | 4.4% |
| 现金转化率经营现金流/净利润 | 4.36× | — |
| 过去12个月自由现金流最近4个季度 | $35.3M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流FCAPPLX
| Q4 25 | $21.3M | $2.0M | ||
| Q3 25 | $7.9M | $-3.7M | ||
| Q2 25 | $3.7M | $-5.2M | ||
| Q1 25 | $4.4M | $-5.1M | ||
| Q4 24 | $22.3M | $4.0M | ||
| Q3 24 | $7.6M | $4.1M | ||
| Q2 24 | $3.5M | $-3.6M | ||
| Q1 24 | $7.2M | — |
自由现金流FCAPPLX
| Q4 25 | $19.9M | $1.6M | ||
| Q3 25 | $7.8M | $-4.2M | ||
| Q2 25 | $3.5M | $-5.7M | ||
| Q1 25 | $4.2M | $-5.4M | ||
| Q4 24 | $21.6M | $3.6M | ||
| Q3 24 | $7.5M | $4.0M | ||
| Q2 24 | $3.3M | $-3.8M | ||
| Q1 24 | $7.1M | — |
自由现金流率FCAPPLX
| Q4 25 | 147.7% | 17.8% | ||
| Q3 25 | 58.6% | -23.7% | ||
| Q2 25 | 27.8% | -36.2% | ||
| Q1 25 | 36.5% | -53.0% | ||
| Q4 24 | 190.7% | 19.6% | ||
| Q3 24 | 68.6% | 22.4% | ||
| Q2 24 | 31.2% | -28.1% | ||
| Q1 24 | 67.2% | — |
资本支出强度FCAPPLX
| Q4 25 | 10.0% | 4.4% | ||
| Q3 25 | 1.2% | 2.8% | ||
| Q2 25 | 2.2% | 2.8% | ||
| Q1 25 | 1.9% | 3.0% | ||
| Q4 24 | 6.3% | 2.3% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | 1.4% | 1.3% | ||
| Q1 24 | 1.5% | — |
现金转化率FCAPPLX
| Q4 25 | 4.36× | — | ||
| Q3 25 | 1.77× | -1.58× | ||
| Q2 25 | 0.99× | -31.91× | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 6.84× | 0.61× | ||
| Q3 24 | 2.62× | 1.27× | ||
| Q2 24 | 1.23× | — | ||
| Q1 24 | 2.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCAP
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
